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avaliaÇÃo ProsPectiva de criaNÇas e
adolesceNtes com feNÓmeNo de 
rayNaud atravÉs da caPilaroscoPia 
PeriuNgueal
Objetivo:Avaliar prospectivamente os achados clínicos
e de capilaroscopia periungueal de uma coorte de crian-
ças e adolescentes com fenômeno de Raynaud sem cri-
térios para doenças reumáticas auto-imunes.
Métodos: Foram incluídos 40 crianças e adolescentes
com fenômeno de Raynaud. Cada paciente foi avalia-
do clinicamente e com exames laboratoriais incluindo
a determinação de anticorpo antinuclear. Na mesma
ocasião foi realizada avaliação capilaroscópica através
de um microscópio óptico com aumentos de 10 e 16
vezes. Todos foram avaliados prospectivamente com
tempo médio entre as avaliações de 1,6 anos.
Resultados:Dos 40 pacientes, 30 (75%) eram do sexo
fe minino, com média de idade de 14,6 anos e tempo
mé dio de evolução de 4,2 anos. A média de idade do
iní cio dos sintomas foi de 10,4 anos e o tempo médio
até o diagnóstico de 1,4 anos. Quatorze (35%) dos 40
pa cientes apresentaram anticorpo antinuclear positivo.
Cinco pacientes (12,5%) apresentaram alterações na
ca pilaroscopia inicial: 4 microangiopatia inespecífica e
1 padrão escleroderma. Três pacientes (7,5%) apresen-
taram alterações na capilaroscopia. Dois pacientes com
padrão escleroderma na ca pilaroscopia apresentaram
durante a evolução doe nça mista do tecido conjuntivo
e hipotireoidismo respectivamente. Em um paciente
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com capilaroscopia normal e presença de auto-anti-
corpos foi diagnosticado lúpus eritematoso sistêmico
após 1 ano da avaliação inicial.
Conclusão:O fenômeno de Raynaud permanece como
primário na maioria dos casos, entretanto a capilaros-
copia periungueal e a determinação de auto-anticorpos
são úteis  para auxiliar na exclusão de doenças reumá-
ticas ou outra doença auto-imune. Nenhuma outra
criança teve diagnóstico de doença reumática auto-imu-
ne sistêmica durante a evolução
Palavras-chave:Capilares; Microscopia; Criança; Ado-
lescente; Fenômeno de Raynaud; Doenças do colágeno.
ProsPective Nailfold caPillaroscoPy
evaluatioN of rayNaud’s PheNomeNoN
iN childreN aNd adolesceNts
Objective: To evaluate prospectively the clinical fea-
tures and nailfold capillaroscopy findings of a cohort of
children and adolescents who presented Raynaud’s
phenomenon (RP) without criteria for autoimmune
rheumatic diseases. 
Methods: 40 children and adolescents with isolated RP
were included. Evidence of systemic autoimmune
rheumatic diseases (SARD) was ruled out by thorough
clinical and laboratory examination. Concomitantly we
also performed wide-field nailfold capillaroscopy eva -
luation using an optical microscope with magnifica-
tions of 10 and 16X. All patients were prospectively re-
evaluated within a mean interval time between evalua -
tions of 1.6 years.
Results: Thirty (75%) out of 40 patients were female
with a mean age of 14.6 years and mean follow-up time
of 4.2 years. The mean age of disease onset was 10.4
years and the mean time until diagnosis was 1.4 years.
Fourteen out of 40 patients (35%) presented antinu-
clear antibodies (ANA). Five (12.5%) patients had al-
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tered nailfold capillaroscopy at first examination: four
presented non-specific microangiopathy and one pre-
sented scleroderma pattern. At the re-evaluation three
patients (7.5%) presented nailfold capillaroscopy al-
terations (two scleroderma pattern and one non-spe-
cific microangiopathy). The two patients who showed
scleroderma pattern at the nailfold capillaroscopy pre-
sented along the follow-up a diagnosis of mixed con-
nective tissue disease and hypothyroidism, respecti -
vely. A girl with normal nailfold capillaroscopy and
presence of autoantibodies was diagnosed with sys-
temic lupus erythematosus after 1 year of initial eva -
luation. None of the other children presented diagno-
sis of SARD along the follow-up.
Conclusions: Primary Raynauds phenomenon re-
mained the diagnosis in most cases in this series of
children and adolescents presenting with initial RP
complaint. Nailfold capillaroscopy and determination
of autoantibodies were useful ancillary tools in the in-
vestigation of possible evolution towards SARD. 
Keywords: Capillaroscopy; Adolescent; Child; Ray-
naud’s phenomenon; Autoimmune rheumatic diseases.   
iNtroductioN
Raynaud’s phenomenon (RP) is a vascular disorder
characterized by episodic and reversible attacks of va-
sospasm with paleness of the extremities, followed by
cyanosis and hyperemia, usually triggered by exposi-
tion to cold or emotional stress. Prevalence of RP in
the general population ranges from 5 to 20%, and in
children aged between 12 and 15 years, the described
prevalence is estimated in up to 15%1-4. Similarly to
adults, it is more common in females and its preva-
lence increases with age5.
RP can be divided into primary or idiopathic, and
secondary. Primary or idiopathic RP comprise up to
90% of RP cases and is characterized by symmetrical
episodes, absence of tissue necrosis, ulceration or gan-
grene, absence of secondary causes (evaluated by
anamnesis and physical evaluation) and of antinu clear
antibodies (ANA), normal levels of acute phase mar -
kers, and no abnormality at  nailfold capillaroscopy
(NFC) 6.
The main cause for secondary RP in children and
adolescents is systemic autoimmune rheumatic disea -
ses (SARD), among which the main members are syste -
mic sclerosis (SSc) and mixed connective tissue disea -
se (MCTD)7,8. RP may represent the initial manifesta-
tion in a considerable number of SARD patients. Iden-
tification of secondary RP with support of NFC can ac-
tually lead to early diagnosis of such diseases, which are
known to present an insidious development9-12. Labo-
ratory examinations such as detection of autoantibo -
dies (ANA, anti-topoisomerase-1 and anti-centromere)
are also helpful for scleroderma characterization. Lite -
rature reports estimate a 4% to 60% RP frequency in
adult patients that developed SARD13-18. Enlarged and
giant capillaries, avascular areas and irregular archi-
tecture at NFC examination were observed in adults
with RP that developed SARD during a 6.5 year follow-
-up19. About 15 to 20% of adult patients with RP and
without criteria for SARD, but possessing autoanti-
bodies and/or NFC abnormalities, are at risk to develo p
some kind of SARD within a 10 year period15,16,20-22. Yet,
these two important predictive factors in adults have
not  been properly studied in children. 
Studies on children with RP suggest that NFC might
distinguish patients with primary RP from those with
RP secondary to SARD23,24. A prospective study with
children and adolescents with RP showed that about
60% of those who developed diseases of systemic scle-
rosis group, presented scleroderma (SD) pattern in ave -
rage 6 months before the onset of the disease, high-
lighting the prospective value of NFC abnormalities re-
garding SARD development25.
In this study, we performed a prospective evaluation
of a cohort of children and adolescents with RP with-
out criteria for SARD and sought to understand the role
of NFC and autoantibody determination in the early
identification of secondary RP.
methods
Forty children and adolescents with RP were consecu-
tively evaluated at the pediatric rheumatology outpa-
tient clinic over the last 2 years. RP was defined as the
presence of paleness, cyanosis or hyperemia of the ex-
tremities triggered by exposure to cold. Inclusion cri-
teria were patients with age up to 18 years old that pre-
sented RP and satisfactory nailfold bed conditions as to
allow for NFC examination. Patients with SARD or 
other systemic diseases were excluded. All patients
were prospectively evaluated in a mean time of 1.6
years (from 6 months to 2 years). 
Anamnesis and physical evaluation were performed
with emphasis on possible skin abnormalities (skin
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thickness, Gottron’s sign, heliotrope, photosensitivity
and nailfold hyperemia), calcinosis, digital infarcts,
digital pitting, arthritis/arthralgia, muscle weakness,
esophageal abnormalities (dysphagia), and pulmonary
abnormalities (dyspnea, dry cough). RP was conside -
red incomplete when one or two of the three consecu -
tive phases (paleness, cyanosis and hyperemia) in the
extremities of the fingers was absent. 
Laboratory evaluation included blood cells count,
testing for acute phase reactions (erythrocyte sedi-
mentation rate – ESR and C-reactive protein test –
CRP), muscle enzymes serum level (glutamic-
-oxaloacetic transaminase – GOT; glutamic-pyruvic
transaminase – GPT; creatinekinase – CK; lactate de-
hydrogenase – LDH), autoantibodies (ANA; anti-dou-
ble-stranded deoxyribonucleic antibodies – anti-DNA;
extractable nuclear antigens – ENA; rheumatoid factor
– RF; anti-topoisomerase-1 or anti-Scl 70; anti-po -
lymyositis-scleroderma – anti-PM-Scl; anti-cardiolipin
IgG and IgM); and hemolytic complement (CH100
and C2). 
Capillaroscopic evaluation was performed by the
same person (MTRAT) in an optical microscope with
10 and 16 times magnification, equipped with a gra -
duated ruler attached to the right eyepiece to allow
counting the number of capillary loops per millimeter
in the distal row. Epi-illumination was provided by in-
candescent tungsten lamp with a green filter, so as to
better highlight the capillaries against the tissue back-
ground. For optimal visualization of the capillary net-
work, the periungueal skin was overlaid with a trans-
parent oleaginous agent. All hand fingers (with ex-
ception of the thumbs) were examined. The patients
were advised not to touch or remove the cuticle (nail-
fold) during one whole month before the examination
to allow optimal stretching of the capillary loops by
the nailfold attached to the nail and to avoid micro
traumas that could jeopardize the examination. The
analysis and interpretation of the various microvascu-
lar phenomena were performed in a semiquantitative
approach as proposed by Andrade et al., with focus on
the number of capillaries per millimeter, number and
extent of avascular areas, number of enlarged and gian t
capillary loops, and number and distribution of areas
of microhemorrhage26.
Enlarged capillaries were defined as those having 4
or more times the width of normal neighbor loops in
the three limbs, ascendant, transition, and descendant.
Giant capillaries were defined as aneurysm-looking
loops with limbs about 10 times or more the width of
normal neighbor loops. Morphological abnormalities
were classified into three types: meandering, bushy,
and bizarre capillaries. Meandering capillaries were de-
fined as tortuous loops where the limbs were inter-
twined and crossed on themselves. Bushy capillaries
were defined as those with small branches in different
directions. Bizarre capillaries were those presenting
with atypical structure, although not conforming to
the types just described.
Capillary devascularization was estimated in two
ways: 1) the number of capillary loops per millimeter
allowed the detection of diffuse devascularization; and
2) the deletion score measured focal devascularization.
The number of capillaries per millimeter was counted
through the eyepiece with a graduated ruler. The final
figure was the average of the linear density of capilla -
ries in the fingers observed. Deletion areas were de-
fined as the lack of two or more successive capillaries,
or avascular areas measuring more than 3mm in ex-
tent. This system was adapted from Lee et al27, and is
graded as follows: Grade 0: No deletion areas; Grade
1: one or two discontinuous deletion areas; Grade 2:
more than two discontinuous deletion areas; Grade 3:
extensive and confluent deletion areas. The final de-
gree corresponded to the mean of the figures ascribed
for each finger. 
Nailfold capillaroscopy was considered normal in
the presence of a palisade of parallel capillary loops
figure 1. Normal capillaroscopy (16 times magnification)
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without relevant morphological abnormalities and
without deletion areas. (Figure 1) Non-specific mi-
croangiopathy was defined as the presence of enlarged
capillaries and other morphological atypias without
capillary deletion (Figure 2). The SD pattern was
charac terized by the presence of enlarged capillaries
or giant capillaries and avascular lesions translating
capillary deletion in a scenario of general distortion of
the usual palisade array of capillary loops (Figure 3).
Intra and inter-observer variability was tested in
20% of the examined individuals. In order to evaluate
the capillaroscopic findings we used the agreement be-
tween two observers (MTRAT/DGPP) by using Kappa
(k>0.80). 
All participants signed the informed consent term for
participation in this study, which was previously appro -
ved by the ethics committee of Hospital São Paulo.
results
Our sample was composed of 40 patients: 75% fema -
les, 75% caucasians, with mean age of 14.6 years (ran -
ging from 6 to 18 years) and mean follow-up time of
4.2 years (from 3 months to 12 years). Mean age of
symptoms onset was 10.4 years (from 2 to 17 years)
and mean age until diagnosis was 1.4 years (from 1
month to 8 years). 
The majority of patients presented arthralgia
(57.5%) on large joints (mainly on knees) and incom-
plete RP (80%) at the first evaluation. The most fre-
quent manifestations were digital cyanosis and pale-
ness. At the initial clinical examination, three patients
presented acute arthritis in addition to RP, but only
one of them had a positive ANA test. No patient
presen ted fever, dysphagia, dyspnea, skin thickness,
digi tal ulcers or digital pulp resorption. Fifteen pa-
tients (37.5%) used nifedipine as treatment for RP.
Clinical da ta and laboratory alterations at the initial
evaluation of children and adolescents with RP are
shown in Table I. 
Initial laboratory examinations presented transito-
ry lymphopenia and also mild alterations in the white
blood cells count. No patient presented anemia (he mo -
globin<11mg/dl), leukopenia (leukocytes <4000/
/mm3) or thrombocytopenia (platelets  <100000/
/mm3). Some patients presented mild transient abnor-
malities in acute phase reactions (ESR and CRP). No
patient presented GOT nor CK increase, but some pa-
tients presented subtle and transient increase in LDH
and GPT serum levels. Anti-cardiolipin antibody was
present in one patient at low levels and with no clini-
cal relation to thromboembolism. Thirteen patients
(32.5%) presented positive ANA: 7 at low titer (1/160)
and/or with non-specific immunofluorescence pattern,
and 3 of these presented negative ANA in the second
evaluation; three other patients had positive ANA at
high titer (≥1/1280) with non-specific ANA pattern
without progressing into some autoimmune disease
during follow-up; and three patients had high titer
figure 2. Non-specific microangiopathy capillaroscopy 
(16 times magnification) figure 3. SD pattern capillaroscopy (16 times magnification)
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ANA (1/1280) with nuclear speckled pattern. These
three patients progressed into a secondary form of RP.
Two of these (5%) ANA-positive patients at high titers
(1/1280) and with speckled pattern also presented
anti-RNP (ribonucleoprotein) antibodies in the first
evaluation and a third one presented homogeneous
ANA pattern (1/1280) and absence of anti-ENA anti-
bodies during follow-up. No patient was positive for
anti-DNA, RF, anti-topoisomerase-1 or anti-PM-Scl an-
tibodies, and none had complement consumption. 
Thirty-four out of the 40 patients initially evalua ted
presented normal NFC (85%), one had inconclusive
result, four had non-specific microangiopathy and one
presented SD pattern (Table 2). All patients were
prospectively evaluated in a mean time of 1.6 years
(from 6 months to 2 years) and three of them (7.5%)
presented capillaroscopic abnormalities along the fol-
low-up: one patient presented non-specific microan-
giopathy and two presented SD pattern. A 13-years
old patient with SD pattern (mean deletion of 1.75,
mean enlarged capillaries/finger of 2, and no giant ca -
pi l laries) in the initial NFC remained with stable
abnor malities two years later in the second NFC. She
presented positive ANA with coarse speckled pattern
at 1/1280 and progressed to mixed connective tissue
di sease (MCTD) two years after initial evaluation. The
two other patients that presented abnormal NFC at the
follow-up evaluation had a normal NFC at baseline: a
12 years old girl that changed into non-specific mi-
croangiopathy but did not develop any clinical evi-
dence of SARD and remained with no autoantibodies
after 1 year; and a 14-years old girl who developed full
SD pattern (mean deletion of 2.8, mean enlarged ca -
pillaries/finger of 0.75 and no giant capillaries) with
worsening of RP, presence of digital ulcers, diffuse
hands edema, hypothyroidism, and nuclear homoge-
neous ANA at 1/1280 after 7 months of initial evalua-
tion. An 11-years old girl that presented initially iso-
lated RP, nuclear coarse speckled ANA at 1/1280, anti-
-RNP antibodies, and normal NFC, progressed to
chronic arthritis, hemolytic anemia, anti-Sm antibo -
dies, and was diagnosed as systemic lupus erithe-
matosus (SLE) 1 year after initial evaluation. Thus, 3
(7.5%) out of 40 patients presented secondary RP
along the follow-up investigation. 
The capillaroscopic findings were fully concordant
among the two observers and in intra-observer evalua -
tion (kappa=1). No inferential statistical analysis was
performed due to the small number of patients that
progressed to secondary RP.
discussioN
RP is still poorly described in pediatrics, with repor ted
fre quencies reaching up to 15% in children and adoles -
table i. iNitial cliNical aNd laboratory data 




Incomplete RP 32 (80)
Complete RP 8 (20)
Arthralgia 23 (57.5)
Skin Abnormalities* 7 (17.5)
Arthritis 3 (7.5)
Muscle weakness 2 (5.0)
Laboratorial data
Acute phase ESR > 25 mm/ 5 (12.5)
reactions /1st hour
CRP > 0.6 mg/L 7 (17.5)
Muscle enzymes GPT (> 56 U/L) 1/37 (2.7)
LDH (> 240 U/L) 3/37 (8.1)
Auto-antibodies ANA Hep-2 13 (32.5)
Anti-ENA** 2 (5.0)
RF 1 (2.5)
ACL IgG/IgM 1 (2.5)/0(0)
*Skin abnormalities: livedo reticularis (N=5), photosensitivity (N=2).
** Two participants with anti-RNP antibodies positivity 
RP: Raynaud’s phenomenon; ESR: erythrocyte sedimentation rate; CRP: 
C-reactive protein; GPT: glutamic-pyruvic transaminase; LDH: lactic
dehydrogenase; ANA: anti-nuclear antibodies; ENA: extractable nuclear
antigens; RF: rheumatoid factor; ACL IgG 
table ii. Nailfold caPillaroscoPy of childreN
aNd adolesceNts with rayNaud’s PheNomeNoN
iN two differeNt occasioNs (N=40)
First Evaluation Second Evaluation*
Normal (34) Normal (37)
Non-specific  Non-specific 
microangiopathy (4) microangiopathy (1)
Inconclusive (1) Inconclusive (0)
SD pattern (1) SD pattern (2)
*Interval between examination: 6 months to 2 years (mean: 1.6 years)
The arrows represent the follow-up changes in the second evaluation of NFC
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cents1-2. Its prevalence increases at adolescence with
mean age at symptoms onset of 10 years, according to
what was observed in our study, and it is also more fre-
quent in females, as observed in 75% of our sample1-5.
RP was incomplete in 80% of our cases, challenging
the diagnosis due to the lack of awareness by patients
and physicians. Therefore, the diagnosis is usually de-
layed, like in our study, where we observed an inter-
val of up to eight years (mean 1.4 years) between RP
onset and diagnosis. In most cases, RP is defined as
primary, as we found in 37/40 patients (92.5% of ca -
ses)6. It is known that primary RP is characterized as
symmetrical attacks, absence of tissue necrosis, accral
ulcers or gangrene, absence of ANA, normal acute
phase reaction and normal NFC. In our 37 primary RP
patients, only very few clinical and laboratory abnor-
malities were observed, and those were transient or
had no clinical relevance. Although we had observed
clinical complaints by a few patients, such as arthral-
gia or muscular weakness, those were only subjective
and non-specific symptoms and the patients did not
progress into any disease. 
Even though we observed the presence of ANA in
13 patients (32.5%), 10 presented low titer and/or
non-specific patterns, and 3 (7.5%) of them had neg-
ative results in the follow-up. Literature describes ANA
presence in up to 12.6% of healthy children and ado-
lescents28. A larger frequency of ANA in our sample
suggests that these patients might not have primary RP
and that longer follow-up period might show deve -
lopment of RP secondary to SARD in additional pa-
tients. These patients would have RP as a risk to de-
velop such diseases. Nevertheless, in 3 patients (7.5%),
the presence of ANA at high titers and speckled pattern
was a predictive factor to progress into SARD, also ac-
cording to literature, which shows that about 15 to
20% of adult patients with RP that have auto-antibo -
dies and/or NFC abnormalities will develop some kind
of SARD in up to 10 years15,16,19-22 . 
Other laboratory abnormalities were also non-spe-
cific such as mild elevation in acute phase reactants, as
well as abnormalities in red and white cell analysis,
and elevation in serum muscular enzyme levels, which
can be altered in several conditions. Since all abnor-
malities were transient, we believe that they were not
pathologically meaningful. 
Regarding NFC, it was normal for most cases, and
those patients with non-specific microangiopathy (4
cases) in the first evaluation, had normal final findings
in the follow-up. Non-specific microangiopathy is des -
cribed as an elementary capillaroscopic abnormality
that is able to progress to SD pattern or it might pro -
gress to normal NFC, as occurred with some of our
patients in the second evaluation22-24. However, 1 pa-
tient who initially did not present clinical features nor
NFC abnormalities that could suggest SARD, presen -
ted NFC abnormalities during the follow-up, which
were compatible to non-specific microangiopathy. This
patient is still being clinically followed. 
The prognostic value of NFC abnormalities has 
been described in adults and sporadically in chil-
dren12,18-20,22,24,25,29. The two patients from our sample
with SD pattern developed clinical abnormalities that
allowed them to be classified as secondary RP, sugges -
ting that SD pattern probably represents a risk factor for
SARD development in children. The first adolescent
did not present any clinical abnormality at first exa -
mination, but already presented NFC abnormalities,
ANA and anti-RNP antibodies. During the follow-up
this patient developed digital ulcers, suggesting MCTD
diagnose. In this regard, Duffy et al. studied NFC in 27
RP children (67% with secondary RP) and suggested
that presence of ANA concomitantly to NFC abnor-
malities were predictive factors to SARD deve lopment23.
The second patient, however, presented a clear SD
pattern in the second capillaroscopic evaluation, con-
comitantly with RP worsening, digital ulcers, diffuse
hand edema, antinuclear antibodies (ANA) and hor-
monal thyroid alterations, with consequent hypothy-
roidism diagnosed 7 months after the initial evalua-
tion. There are very scarce literature reports of hy -
po thy roidism associated with secondary RP during
childhood30-33. In addition, the few reports of NFC
abnor malities in hypothyroidism refer to capillary im-
maturity and a few giant capillaries although the ves-
sels were not found to be tortuous and no SD pattern
as in our patient’s NFC30-32. For this reason, we cannot
exclude the possibility that this patient might develop
SARD in the future. 
The patient that evolved with SLE 1 year after the
initial evaluation presented normal NFC at both occa-
sions. Studies in patients with SLE and RP suggest the
detection of other changes needs higher magnification
of 100 to 200 fold and 10 and 16 times magnification
could not be enough to detect alterations34. However
NFC alterations were mild non-specific and charac-
terized by long and tortuous loops, and sometimes
small petechiae.
In a prospective study with mean follow-up period
of 2 years, Pavlov-Dolijanovic et al. evaluated 250 chil-
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dren and adolescents up to 20 years old with RP25. As
we observed in our study, the majority presented nor-
mal NFC or non-specific findings (only 4% with SD
pattern). Children and adolescents who developed
scleroderma spectrum disorders showed definite SD
pattern 6 months before the clinical expression of the
disease. This evidences the prognostic value of NFC
on SARD development. However, only 10 of the 59
patients who developed secondary RP presented NFC
changes at baseline; this meaning that the majority of
patients with systemic rheumatic diseases from this
study did not have prior NFC alterations25. Due to the
relevance of NFC in distinguishing primary from se -
condary RP in rheumatic diseases, this examination is
recommended 6 monthly when RP is present10,25,35. 
NFC has a few limitations indeed, such as depen-
dency of skin transparency, and integrity of nailfold, in
addition to the observer’s subjectivity and his experien -
ce to achieve accurate results. In this regard, it shoud
be emphasized that the SD pattern capillaroscopic de -
finition in the present study was based on agreement
of two experienced readers. Another limitation was
that we did not perform videocapillaroscopy. Al-
though, some authors claim that this exam is more ac-
curate to discriminate giant or enlarged capillaries36,37,
our group has recently demonstrated that conventional
widefield NFC has equivalent accuracy for the detec-
tion and quantitation of the SD pattern38.
We conclude that clinical and laboratory examina-
tions with NFC and ANA determination are essential
to delineate the etiology of RP in children and adoles-
cents. Although RP in childhood is most likely to re -
present primary RP, NFC and ANA are important tools
in the investigation of these patients because they may
detect early abnormalities that indicate seldomly un-
suspected secondary RP and represent a risk factor for
developing a SARD within months or years. Therefore,
NFC is an important tool to predict the development
of SARD. Due to the lack of studies with significant ca-
suistic, multicenter prospective studies are needed in
order to clarify more properly the NFC importance in
children and adolescents with RP phenomenon. 
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